Literature DB >> 23284

Antihypertensive drugs: clinical pharmacology and therapeutic use.

G L Wollam, R W Gifford, R C Tarazi.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 23284     DOI: 10.2165/00003495-197714060-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  257 in total

Review 1.  PHARMACOLOGY OF RESERPINE AND ITS IMPLICATIONS FOR ANESTHESIA.

Authors:  M H ALPER; W FLACKE; O KRAYER
Journal:  Anesthesiology       Date:  1963 Jul-Aug       Impact factor: 7.892

2.  Studies on hydralazine; evidence for a peripheral site of action.

Authors:  A STUNKARD; L WERTHEIMER; W REDISCH
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

3.  Effects of guanethidine and methyldopa on a standardized test for renin responsiveness.

Authors:  S C Lowder; G W Liddle
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

4.  The fate of guanethidine in two hypertensive patients.

Authors:  C McMartin; R K Rondel; J Vinter; B R Alln; P M Humberstone; A W Leishman; G Sandler; J L Thirkettle
Journal:  Clin Pharmacol Ther       Date:  1970 May-Jun       Impact factor: 6.875

5.  Reversal of sympathetic nerve blockade: a comparison of dopa, dopamine, and norepinephrine with their alpha-methylated analogues.

Authors:  E C Conradi; T E Gaffney; D A Fink; J S Vangrow
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

6.  Clinical use of furosemide.

Authors:  F C Reubi
Journal:  Ann N Y Acad Sci       Date:  1966-11-22       Impact factor: 5.691

7.  Beta-adrenergic receptor blockade and renal function.

Authors:  D J Warren
Journal:  Am Heart J       Date:  1976-02       Impact factor: 4.749

8.  Pharmacokinetics of methyldopa in man.

Authors:  K C Kwan; E L Foltz; G O Breault; J E Baer; J A Totaro
Journal:  J Pharmacol Exp Ther       Date:  1976-08       Impact factor: 4.030

Review 9.  Pharmacological effects of labetalol in man.

Authors:  D A Richards
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

10.  Assessment of selective beta-adrenoceptor blockade in man.

Authors:  R H Briant; C T Dollery; T Fenyvesi; C F George
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

View more
  4 in total

1.  Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.

Authors:  M M El-Mehairy; A Shaker; M Ramadan; S Hamza; S S Tadros
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

2.  Approach to drug therapy for hypertension.

Authors:  O G Kuchel; W A Mahon; J K McKenzie; R I Ogilvie
Journal:  Can Med Assoc J       Date:  1979-03-03       Impact factor: 8.262

3.  Diuretic treatment of resistant hypertension.

Authors:  L E Ramsay; J H Silas; S Freestone
Journal:  Br Med J       Date:  1980-10-25

4.  Liver drug metabolism and blood pressure response to a lipophilic and hydrophilic beta blocker.

Authors:  S Säkö; E A Sotaniemi; M Anttila
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Apr-Jun       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.